Thursday, May 22, 2025
3:00PM – 4:00PM ET
Please note this TeleECHO program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.
PRESENTING FACULTY
 |
Jason S. Slakter, MD Partner, Vitreous Retina Macula Consultants of New York Clinical Professor of Ophthalmology, New York University School of Medicine New York, New York |
PROGRAM OVERVIEW
This series of TeleECHO meetings is designed to assist ophthalmologists and retina specialists in enhancing the accuracy and timeliness of geographic atrophy (GA) diagnoses. The program aims to streamline referrals for patients who may benefit from GA treatment and improve patient education on GA, including its progression and prognosis. Through in-depth discussions, it will deepen clinicians’ understanding of the complement system’s role in GA pathogenesis and expand their knowledge of novel complement inhibition therapies. Additionally, the program will strengthen familiarity with efficacy and safety data of complement inhibitors, clarify indications, dosing, and adverse events of approved GA treatments, and refine the selection of appropriate patients for complement inhibition therapy.
TARGET AUDIENCE
This activity is designed to educate ophthalmologists and retina specialists who care for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Interpret diagnostic imaging of GA lesions to identify GA early and its progression to effectively manage or refer patients and collaborate among eye care physicians
- Compose individualized patient education that ensures a thorough understanding of the disease, its progression, and its prognosis
- Describe the role of the complement system in the pathogenesis of GA
- Evaluate current efficacy and safety data that guide the clinical use of complement inhibition therapies for the treatment of GA
- Identify safety considerations with complement inhibition therapies for the treatment of GA to be able to assess and educate patients with GA on their individual risk-benefit ratio of treatment
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
